Transcranial Direct Current Stimulation for Depression
ConditionUnipolar Depression
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age22+
SponsorSoterix Medical
About this trial
This study will test the efficacy of transcranial direct current stimulation (tDCS) combined with mindfulness, remotely-delivered using a telemedicine protocol in 25 adults with unipolar depression.
Eligibility criteria
Qualifiers
Clinically stable patients that meet criteria for diagnosis of MDD according to DSM-V-TR and confirmed with the Mini International Neuropsychiatric interview
Currently experiencing a major depressive episode of at least 4 week's duration as part of a unipolar depression
QIDS-SR score >11 on all three days of screening week (Days 1,3, 7)
Scored at least 17 (inclusive) on the HDRS-17 at trial entry
Disqualifiers
Failure to respond to at least 2 antidepressant medications
Drug or alcohol abuse or dependence in the preceding 3 months
Concurrent benzodiazepine medication
High suicide risk assessed during clinician screening at baseline interview.
Trial design
Treatments tested in this trial
- transcranial direct current stimulation (tDCS) and mindfulness instruction
- Sham tDCS and Mindfulness
Treatment groups
25 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov